← back to search

Márcio Nucci

Universidade Federal do Rio de Janeiro · BR
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Neutropenia and Cancer Infections, and Acute Myeloid Leukemia Research.
h-index
70
citations
24,135
works
406
NIH funding
primary concept
Medicine
email

Recent publications

Clinical Features and Mortality of Chronic Pulmonary Aspergillosis in Brazil: a Multicenter Cohort Study.
2026cited by 0position: contributordoi
Repeat Blood Cultures in Persistent Febrile Neutropenia
Clinical Infectious Diseases 2026cited by 0position: contributordoi
Managing Breakthrough Fungal Infections in Hematologic Patients: Determinants and Practical Management from a Latin American Perspective on Behalf of INFOCUS LATAM-ISHAM Working Group.
2026cited by 0position: contributordoi
Redefining antifungal prophylaxis in acute leukaemia in the era of targeted therapies
Journal of Antimicrobial Chemotherapy 2026cited by 0position: contributordoi
Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit
The Brazilian Journal of Infectious Diseases 2025cited by 4position: contributordoi
Real-World Experience with Isavuconazole for Invasive Aspergillosis in Hematologic Patients with and Without COVID-19 in Brazil.
2025cited by 0position: contributordoi
Immunoglobulin after bispecifics requires randomized trial
Blood Advances 2025cited by 0position: contributordoi
<i>Aspergillus fumigatus</i>—a systematic review to inform the World Health Organization priority list of fungal pathogens
Medical Mycology 2024cited by 35position: middledoi
<i>Pichia kudriavzevii</i> (<i>Candida krusei</i>): A systematic review to inform the World Health Organisation priority list of fungal pathogens
Medical Mycology 2024cited by 33position: middledoi
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
EClinicalMedicine 2024cited by 30position: middledoi
Aspergillus fumigatus-a systematic review to inform the World Health Organization priority list of fungal pathogens.
2024cited by 21position: contributordoi
Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens.
2024cited by 18position: contributordoi
<i>Fusarium</i> species,<i>Scedosporium</i> species, and <i>Lomentospora prolificans</i>: A systematic review to inform the World Health Organization priority list of fungal pathogens
Medical Mycology 2024cited by 16position: middledoi
Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine
Hematology, Transfusion and Cell Therapy 2024cited by 8position: contributordoi
Fusarium species,Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens.
2024cited by 8position: contributordoi
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
2024cited by 7position: contributordoi
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
2024cited by 5position: contributordoi
Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH
Hematology, Transfusion and Cell Therapy 2024cited by 3position: contributordoi
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
2024cited by 0position: contributordoi
Evaluation of the knowledge of hematologists about the management of infectious complications in hematologic patients
Hematology, Transfusion and Cell Therapy 2024cited by 0position: contributordoi
Invasive fusariosis
Clinical Microbiology Reviews 2023cited by 60position: contributordoi
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Frontiers in Immunology 2023cited by 36position: middledoi
Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022
The Lancet Infectious Diseases 2023cited by 34position: middledoi
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis
Medical Mycology 2023cited by 31position: middledoi
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.
2023cited by 17position: contributordoi
Infections in patients with chronic lymphocytic leukemia
Hematology, Transfusion and Cell Therapy 2023cited by 16position: contributordoi
Invasive Fungal Infections Associated with COVID-19
Journal of Fungi 2023cited by 14position: contributordoi
Should patients with acute myeloid leukemia treated with venetoclax-based regimens receive antifungal prophylaxis?
Leukemia Research 2023cited by 10position: contributordoi
Practical issues related to non-Aspergillus invasive mold infections
Molecular Aspects of Medicine 2023cited by 6position: contributordoi
Invasive Aspergillosis in Patients with Acute Leukemia: Comparison Between Acute Myeloid and Acute Lymphoid Leukemia.
2023cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 35 papers (2019–2026)Arnaldo Lopes Colombo · Instituto Adolfo Lutz7 papers (2019–2026) · 5 papers (2021–2026)Oliver A. Cornely · Agostino Gemelli University Polyclinic4 papers (2013–2021)Jan‐Willem C. Alffenaar · The University of Sydney3 papers (2024–2024)Ana Alastruey‐Izquierdo · Instituto de Salud Carlos III3 papers (2024–2024)Andreas H. Groll · TU Dortmund University3 papers (2021–2023)Justin Beardsley · Nicolae Testemițanu State University of Medicine and Pharmacy3 papers (2024–2024)David W. Denning · Manchester Academic Health Science Centre3 papers (2024–2026)Johan Maertens · Ospedale Policlinico San Martino3 papers (2012–2021)Mariana Guaraná · Elsevier, Inc.3 papers (2023–2026)Flávio Queiroz‐Telles · Hospital de Clínicas Universidade Federal do Paraná2 papers (2015–2025)Francisco M. Marty · Dana-Farber Cancer Institute2 papers (2019–2021)Alessandro Cassini · Service de la Santé Publique2 papers (2024–2024)P. Lewis White · Public Health Wales2 papers (2021–2023)Valeria Gigante · World Health Organization2 papers (2024–2024)Catherine Cordonnier · Université Paris-Est Créteil2 papers (2021–2023)Thomas S. Harrison · The Heart Research Institute2 papers (2024–2024)Retno Wahyuningsih · Universitas Kristen Indonesia2 papers (2024–2024)Dimitrios P. Kontoyiannis · The University of Texas MD Anderson Cancer Center2 papers (2014–2015)